Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products. It specializes in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies.
Akorn was acquired by Fresenius Kabi AG on April 24, 2017.

Type
Public
Parent Company
Fresenius Kabi
HQ
Lake Forest, US
Founded
1948
Size (employees)
2,261 (est)
Website
akorn.com
Akorn was founded in 1948 and is headquartered in Lake Forest, US

Akorn Office Locations

Akorn has offices in Lake Forest, Ann Arbor, Gurugram, Jersey and in 3 other locations
Lake Forest, US (HQ)
300 1925 W Field Ct
Gurugram, IN
DLF Building Number 9B
Ann Arbor, US
2929 Plymouth Rd
Show all (7)

Akorn Data and Metrics

Akorn Financial Metrics

Akorn's revenue was reported to be $253.4 m in Q1, 2017
USD

Revenue (Q1, 2017)

253.4 m

Gross profit (Q1, 2017)

149.1 m

Gross profit margin (Q1, 2017), %

59%

Net income (Q1, 2017)

41 m

EBIT (Q1, 2017)

74.8 m

Market capitalization (17-Aug-2017)

4.1 b

Cash (31-Mar-2017)

307.4 m
Akorn's current market capitalization is $4.1 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

317.7 m593.1 m985.1 m1.1 b

Revenue growth, %

87%66%13%

Cost of goods sold

145.8 m295.5 m105.5 m442.6 m

Gross profit

171.9 m297.6 m879.5 m674.3 m

Gross profit Margin, %

54%50%89%60%

R&D expense

42.6 m

General and administrative expense

197.5 m

Operating expense total

83.7 m200.9 m301.4 m346.7 m

EBIT

88.2 m96.7 m294.6 m327.6 m

EBIT margin, %

28%16%30%29%

Interest expense

8.6 m35.7 m12.6 m42.7 m

Pre tax profit

82.9 m59.1 m49.5 m271.3 m

Income tax expense

30.5 m23.3 m16.7 m87.1 m

Net Income

52.4 m35.3 m150.8 m184.2 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

150.7 m132.7 m227.4 m220.9 m256.8 m268.3 m280.7 m284.1 m253.4 m

Cost of goods sold

74.1 m81 m97.2 m92.5 m93.8 m105.3 m109 m113.9 m104.3 m

Gross profit

76.7 m51.7 m130.2 m128.4 m163 m163 m171.8 m170.2 m149.1 m

Gross profit Margin, %

51%39%57%58%63%61%61%60%59%

R&D expense

9.1 m7.9 m9.3 m10.6 m10.4 m9.5 m8.9 m10.6 m11.3 m

General and administrative expense

22 m27.8 m30 m35.2 m45 m49.1 m54 m47.1 m47.5 m

Operating expense total

31 m35.7 m39.3 m45.8 m55.5 m58.6 m62.8 m57.7 m58.8 m

EBIT

16.3 m(6 m)73.3 m66.1 m90.8 m87.6 m92.4 m86.8 m74.8 m

EBIT margin, %

11%(5%)32%30%35%33%33%31%30%

Interest expense

(7.9 m)(11.8 m)(13.5 m)(13.2 m)(12.7 m)(11.5 m)(10.8 m)(10.3 m)(9.6 m)

Pre tax profit

14.3 m(18.5 m)58.3 m50.4 m74 m66.6 m80.3 m75.2 m65.3 m

Income tax expense

5.3 m(6.9 m)20.8 m17.9 m26 m24.7 m18.3 m27.3 m24.3 m

Net Income

8.5 m(11.7 m)37.5 m70 m118 m41.9 m62 m47.9 m41 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

34.2 m70.7 m346.3 m200.8 m

Accounts Receivable

283.2 m

Inventories

5.8 m30.9 m20 m174.8 m

Current Assets

168.9 m494.3 m751.2 m685.8 m

PP&E

82.1 m143.8 m179.6 m238.4 m

Goodwill

29.8 m278.8 m284.7 m284.3 m

Total Assets

431.8 m1.9 b2.1 b2 b

Accounts Payable

23 m44.1 m46 m59.5 m

Total Debt

810 m

Current Liabilities

61.2 m134.2 m231.5 m175.6 m

Non-Current Liabilities

110.4 m1.4 b1.3 b979 m

Total Liabilities

171.6 m1.5 b1.5 b1.2 b

Retained Earnings

15.4 m50.7 m180 m319.3 m

Total Equity

260.2 m621.6 m819.2 m

Debt to Equity Ratio

1 x

Debt to Assets Ratio

0.4 x

Financial Leverage

1.7 x3.4 x2.4 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

107.9 m131.5 m123.5 m257.1 m314.5 m141 m156.3 m174.1 m307.4 m

Accounts Receivable

140 m145.2 m190.7 m130.8 m138.9 m172.2 m205 m263 m233.7 m

Inventories

108.9 m132.8 m149.4 m156.3 m175.9 m190.9 m188 m179.7 m172.3 m

Current Assets

397.2 m494.1 m543.9 m607 m698.8 m530 m593.9 m644.2 m736 m

PP&E

135.7 m139.4 m176 m179.2 m177.4 m186.3 m195.7 m216 m252.7 m

Goodwill

196 m290.6 m285.7 m285.4 m284.7 m284.7 m284.4 m284.6 m285 m

Total Assets

1.2 b1.9 b2 b2 b2.1 b1.9 b1.9 b2 b2 b

Accounts Payable

37.8 m36.7 m58 m45.5 m57.8 m45.9 m48.3 m55.2 m50.6 m

Current Liabilities

103.8 m133.8 m153.9 m199 m237.7 m194.6 m138.8 m155.5 m174.8 m

Non-Current Liabilities

825.5 m1.4 b1.4 b1.3 b1.3 b994.7 m998 m995.4 m980.5 m

Retained Earnings

33.7 m22.1 m66.8 m99.3 m147.3 m221.9 m283.9 m306.8 m360.3 m

Total Equity

442.2 m535.9 m584.5 m666.6 m778.3 m810 m870.4 m

Financial Leverage

4.5 x3.8 x3.6 x2.8 x2.5 x2.4 x2.3 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

52.4 m35.3 m37.5 m184.2 m

Depreciation and Amortization

7.4 m44.1 m17.1 m65.7 m

Accounts Receivable

(14 m)

Inventories

(3.8 m)(13 m)2.9 m(6.5 m)

Accounts Payable

2 m11 m7.9 m6.1 m

Cash From Operating Activities

57.3 m30.9 m45.3 m167.8 m

Purchases of PP&E

(11.6 m)(29.6 m)(7.1 m)(74.9 m)

Cash From Investing Activities

(66.9 m)(966.5 m)(29.4 m)(72.9 m)

Cash From Financing Activities

3.1 m972.3 m36.8 m(240.3 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

8.5 m(11.7 m)37.5 m70 m118 m41.9 m62 m47.9 m41 m

Depreciation and Amortization

8.6 m14 m21.1 m44.7 m63.8 m16.5 m16.4 m16.5 m15.5 m

Accounts Payable

37.8 m36.7 m7.9 m(3.6 m)9.4 m45.9 m48.3 m55.2 m50.6 m

Cash From Operating Activities

45.3 m181 m252.1 m

Purchases of PP&E

(7.1 m)(15.6 m)(21.6 m)

Cash From Investing Activities

(29.4 m)(41.2 m)(49.2 m)

Cash From Financing Activities

36.8 m46.5 m41.1 m
USDY, 2017

Revenue/Employee

112.1 k

Financial Leverage

2.3 x

Akorn Market Value History

Akorn Median Salaries

Source: 75 public H-1B filings from Akorn

Traffic Overview of Akorn

Akorn Company Life and Culture

You may also be interested in